State Strategies to Expand Access to Medication-Assisted Treatment (MAT) for Opioid Use Disorder (2019)
This report identifies, and links to examples of, the many potential strategies state policy-makers can employ to expand access to MAT and help millions more Americans with substance use disorders become and remain well.
Defense Lawyers and the Opioid Epidemic: Advocating for Addiction Medication (2018)
Explains how defense attorneys can advocate for their clients’ right to life-saving medication to treat opioid use disorder (OUD). Provides an overview of effective treatment for OUD, the ways in which criminal justice agencies prohibit that treatment, why they do so, why that is harmful and illegal, and steps defense attorneys can take to fight for their clients’ access to these medications.
Medication-Assisted Treatment (MAT) Advocacy Toolkit (2016)
This toolkit can help people fight for their right to medication-assisted treatment (MAT) for opioid addiction when courts, criminal justice and child welfare agencies, or employers do not allow it. MAT involves the use of medications, such as methadone, buprenorphine/naloxone (Suboxone) and injectable naltrexone (Vivitrol), in combination with counseling. Dozens of studies have shown that MAT reduces illicit drug use, crime, and communicable disease. The toolkit also includes resources for attorneys and other advocates.
Medication-Assisted Treatment in Drug Courts: Recommended Strategies (2016)
This groundbreaking report shares successful strategies for use of medication-assisted treatment (MAT) in drug courts. In-depth profiles of courts with effective MAT programs, along with sections such as “Nine Components of Successful MAT Programs” and ”Specific Issues for Rural Courts,” address concerns that often prevent courts from using this scientifically-proven opioid addiction treatment.
Attorney's Guide – Addiction Medication and Your Client (2019)
A two-page guide for attorneys whose clients are being forced off medication-assisted treatment (MAT) for opioid addiction. Includes answers to frequently asked questions about MAT and offers strategies for attorneys to advocate for their clients’ health and recovery.
Confronting an Epidemic: The Case for Expanding Access to Medication-Assisted Treatment to Address the Heroin and Opioid Epidemic (2015)
This report calls for making effective medications for addiction available through insurance coverage; enforcing public and private consumer protection requirements; and eliminating obstacles resulting from misinformation and lack of training. It also advocates for increased utilization of medication assisted treatment (MAT) in the criminal justice system, including: promoting treatment alternatives to incarceration where appropriate; improving availability of MAT services in prisons; and placing a greater emphasis on creating pathways to recovery programs.
Legality of Denying Access to Medication Assisted Treatment in the Criminal Justice System (2011)
A report by LAC that explains why criminal justice agencies violate federal anti-discrimination laws and the U.S. Constitution when they deny access to addiction medications—such methadone, buprenorphine, and naltrexone—to treat opioid addiction.
Roadmap for Promoting Health and Justice: A Smarter, More Effective National Drug and Alcohol Policy
This landmark 2016 report from LAC’s Arthur Liman Policy Institute provides a comprehensive and detailed set of recommendations for improving our national drug and alcohol policies to improve health and public safety and save lives and resources.
Advocating for Your Recovery: What to Do When Ordered off Medication (2016)
Explains how people in medication-assisted treatment (MAT) for opioid addiction, as well as their treatment programs and advocates, can advocate to get in or stay in the treatment they need. Includes a sample letter to courts or probation advocating to stay on MAT. For a Word version of the sample letter, click here
Driving on Methadone or Suboxone: DUI? (2016)
Driving on Methadone or Suboxone: DUI? Explains what people can do if they are arrested for driving under the influence merely because they are in methadone maintenance treatment or take prescribed Buprenorhpine-naloxone (Suboxone).
Medication-Assisted Treatment for Opioid Addiction: Myths and Facts (2016)
This “myth and fact” sheet addresses common misconceptions about medications used to treat opioid addiction. It can help educate criminal justice agencies, child welfare agencies, employers and others about why it is critical to include medications, such as such as methadone, buprenorphine-naloxone (e.g., Suboxone) and injectable naltrexone (e.g., Vivitrol), in the range of treatment options available to people with opioid addiction.
Know Your Rights: Are You in Recovery from Alcohol or Drug Problems? Rights for Individuals on Medication-Assisted Treatment (2009)
This brochure is a companion piece to Know Your Rights: Are You in Recovery from Alcohol or Drug Problems?, and describes the specific legal issues faced by people in Medication-Assisted Treatment—such as methadone, buprenorphine, or naltrexone—for opioid addiction.
Methadone Maintenance Treatment: Memorandum of Driving & Psychomotor Studies and Background Information about Methadone Treatment (April 2000)
This packet of information contains: (1) a memorandum summarizing recent literature and studies about the effect of methadone treatment on patients’ driving ability as well as psychomotor and intellectual functioning; (2) the actual articles and studies referenced in the memorandum; and (3) background information about methadone treatment. It is a very useful resource for people trying to combat discrimination based on participation in methadone treatment.
Health Policy Reform: A Roadmap for Smarter and More Effective Alcohol and Drug Policies
This landmark report from Legal Action Center and the State Associations of Addiction Services makes specific and comprehensive recommendations to improve the national response to addiction.
Sample Treatment Provider Letter Supporting Medication-Assisted Treatment
Sample letter treatment providers can use to support patients ordered off MAT by criminal justice and child welfare agencies. Click here for a word version.
Defense Attorneys & the Opioid Epidemic: Asserting Your Clients’ Right to Addiction Medication (2016)
This training explains how criminal defense attorneys can assert their clients’ right to addiction medication.
Know Your Rights: Medication-Assisted Treatment—Special Anti-Discrimination Issues (August 2009)
This webinar provides an overview of federal laws prohibiting discrimination against people with disabilities, and how those laws protect people in medication-assisted treatment for addiction (such as methadone, buprenorphine, or naltrexone).